The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Influence of polymorphisms discovered in cell-based model of cytarabine sensitivity on outcome in pediatric AML: A Children's Oncology Group Study.
Christine L. Phillips
No relevant relationships to disclose
Adam Lane
No relevant relationships to disclose
Gretchen Radloff
No relevant relationships to disclose
Robert B Gerbing
No relevant relationships to disclose
Todd Allen Alonzo
No relevant relationships to disclose
Beverly Lange
No relevant relationships to disclose
Alan S. Gamis
No relevant relationships to disclose
Christine M. Hartford
No relevant relationships to disclose
M. Eileen Dolan
No relevant relationships to disclose
Stella Davies
No relevant relationships to disclose